Increased expression of matrix metalloproteinases in the uterine cervix of postmenopausal women

Journal of Lower Genital Tract Disease

Volumn 7, Issue 1, 2003, Pages 36-43

  Moalli, Pamela A ^a,b   Klingensmith, Wendy L ^a,b   Meyn, Leslie A ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cervical atrophy; Matrix metalloproteinase; Menopause; Tissue inhibitors of matrix metalloproteinase

Indexed keywords

COLLAGEN TYPE 1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GELATINASE A; GELATINASE B; HYDROXYPROLINE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; ATROPHY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROBLAST CULTURE; HUMAN; HYSTERECTOMY; PILOT STUDY; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STROMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX DISEASE; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 0038168807     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200301000-00009     Document Type: Article

References (29)

1. Danforth DN. The morphology of the human cervix. Clin Obstet Gynecol 1983;26:7-13.
2. Fata JE, Ho AT, Leco KJ, Moorehead RA, Khokha R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: Functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 2000;57:77-95.
3. Gorodeski GI. Effects of menopause and estrogen on cervical epithelial permeability. J Clin Endocrinol Metab 2000;85:2584-95.
4. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
5. Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED, ed. Cell Biology of the Extracellular Matrix. 2nd ed. New York: Plenum Publishing Co; 1991:255-302.
6. Murphy G, Stanton H, Cowell S, Butler G, Knauper V, Atkinson S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS 1999;107:38-44.
7. Denison FC, Riley SC, Elliott CL, Kelly RW, Calder AA, Critchley HOD. The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix. Mole Hum Reprod 2000;6:541-8.
8. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10-7.
9. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 1994;218:325-9.
10. Woessner JE Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1960;93:440.
11. Moalli PA, Klingensmith WL, Meyn LA, Zycynski HM. Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor. Am J Obstet Gynecol 2002;187:72-9.
12. Morrione TG, Seifter S. Alterations in the collagen content during pregnancy and postpartum involution. J Exp Med 1962;115:357-65.
13. Woessner JF, Brewer TH. Formation and breakdown of collagen and elastin in the human uterus during pregnancy and postpartum involution. Biochem J 1963;89:75-82.
14. Uldbjerg N, Ekman G, Malmstrom A, Olsson K, Ulmsten U. Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans and collagenolytic activity. Am J Obstet Gynecol 1983;147:662-6.
15. Winkler M, Oberpichler A, Tschesche H, Ruck P, Fischer DC, Rath W. Collagenolysis in the lower uterine segment during parturition at term: Correlations with stage of cervical dilatation and duration of labor. Am J Obstet Gynecol 1999;181:153-8.
16. Shimizu K, Furuya T, Takeo Y, Sherama K, Maekawa K. Clearance of materials from breakdown of uterine collagen in mice during postpartum involution. Acta Anat 1983;116:10-3.
17. Castelo-Branco C, Duran M, Gonzalez-Merlo J. Skin collagen changes related to age and hormone replacement therapy. Maturitas 1992;15:113-9.
18. Brincat M, Versi E, Moniz CF, Magos A, De Traffrd J, Studd JW. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987;70:123-7.
19. Sato T, Ito A, Mori Y, Yamashita K, Hayakawa T, De Nagase H. Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem J 1991;275:645-50.
20. Imada K, Itoh A, Itoh Y, Negase H, Mori Y. Progesterone increases the production of tissue inhibitor of metalloproteinase-2 in rabbit uterine cervical fibroblasts. FEBS 1994;341:109-12.
21. Imada K, Ito A, Sato T, Namiki M, Negase H, Mori Y. Hormonal regulation of matrix metalloproteinase 9/gelatinase B gene expression in rabbit uterine cervical fibroblasts. Biol Reprod 1997;56:575-80.
22. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci USA 1992;89:11789-92.
23. McCawley LJ, Matrisam LM. Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol 2001;13:534-40.
24. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001;73:449-59.
25. Polette M, Nawrocki B, Gilles C, Sato H, Seiki M, Tournier JM, et al. MT-MMP expression and localization in human lung and breast cancer cells. Virchows Arch 1996;428:29-35.
26. Nomur H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995;55:3263-6.
27. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, et al. Expression and tissue localization of membrane types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997;57:2055-60.
28. Shofuda K, Nagashimo Y, Kawahara K, Yasumtsu H, Miki K, Miyasaki K. Elevated expression of membrane type-1 and -3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. Lab Invest 1998;78:915-23.
29. Hurskainen T, Seiki M, Apte SS, Syrjakallio-Ylitalo M, Sorsa T, Oikarinen A, et al. Production of membrane-type matrix metalloproteinases in early human placenta. A possible role in placental implantation? J Histochem Cytochem 1998;46:221-9.